- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06745674
Online Intervention for Cancer Patients
Effectiveness of Internet-based Acceptance and Commitment Therapy for Cancer Patients: A Pilot Randomized Controlled Trial Using Mixed Methods
This study will focus on supporting cancer patients who often experience emotional challenges like anxiety and depression. It will test a two-week online program called Acceptance and Commitment Therapy (ACT), designed to help people manage difficult emotions and focus on what matters most in their lives.
The program will include short, easy-to-follow sessions covering helpful strategies like accepting distress and staying present in the moment. Participants will be randomly assigned to either join the ACT program or wait for the program while continuing their usual care. The study aims to determine whether the ACT program can reduce psychological distress, anxiety, and depression in cancer patients. The study will use a mixed-methods approach, combining both quantitative data (such as changes in distress, anxiety, and depression) and qualitative insights from participant interviews. This will help us gain a deeper understanding of how the ACT program may support the psychological distress of cancer patients.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Hubei
-
Wuhan, Hubei, China, 430079
- Hubei Cancer Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- age 18 and above;
- diagnosed cancer with a clear disease course
- fluent in Chinese with the ability to read and understand questionnaires independently;
- ability to operate a smartphone independently;
- not participating in or intervening in other clinical studies.
Exclusion Criteria:
- younger than 18 years of age
- unable to use a smartphone
- have significant cognitive impairment or a serious systemic disease or psychiatric disorder
- concurrently participating in other clinical studies or undergoing other psychotherapy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Waitlist control group
|
|
|
Experimental: ACT group
|
The study utilized a specially tailored internet-based self-help ACT program for cancer patients.
It consisted of an introductory module and six core intervention modules: (1) Refusing Avoidance; (2) Accepting Distress; (3) Living in the Present Moment; (4) Observing Yourself Psychologically; (5) Exploring Meaningful Values; and (6) Committing to Action.
Each module, designed to take 30-60 minutes, was delivered over a two-week period.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Psychological Distress
Time Frame: Baseline, one week post-baseline, and post-intervention (immediately after the 2-week intervention)
|
Psychological distress is assessed using the Distress Thermometer (DT) (Holland et al., 2013).
Scores range from 0 (no distress) to 10 (extreme distress), with higher scores reflecting greater levels of psychological distress.
|
Baseline, one week post-baseline, and post-intervention (immediately after the 2-week intervention)
|
|
Anxiety and Depression
Time Frame: Baseline, one week post-baseline, and post-intervention (immediately after the 2-week intervention)
|
Anxiety and depression are measured using the Hospital Anxiety and Depression Scale (HADS) (Zigmond & Snaith, 1983), a 14-item questionnaire comprising separate subscales for anxiety and depression.
Each item is scored on a 4-point Likert scale, and higher scores reflect greater severity of anxiety and depression symptoms.
|
Baseline, one week post-baseline, and post-intervention (immediately after the 2-week intervention)
|
|
Acceptability
Time Frame: Post-intervention (immediately after the 2-week intervention)
|
Acceptability is evaluated using the Client Satisfaction Questionnaire (CSQ-8) (Larsen et al., 1979).
This 8-item measure uses a 4-point Likert scale (1 = low satisfaction to 4 = high satisfaction), with higher scores indicating greater satisfaction with the treatment.
|
Post-intervention (immediately after the 2-week intervention)
|
|
Feasibility outcomes
Time Frame: Post-intervention (immediately after the 2-week intervention)
|
Feasibility is evaluated using retention rate and intervention completion rate.
Retention rate reflects the percentage of participants who successfully completed all study-related measurements throughout the trial.
|
Post-intervention (immediately after the 2-week intervention)
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- IRB-202311017b
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
University of Michigan Rogel Cancer CenterCompletedCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); Atrium Health Wake Forest BaptistRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Vanderbilt-Ingram Cancer CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
University of California, San FranciscoBristol-Myers Squibb; PfizerTerminatedStage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Metastatic Colorectal Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal... and other conditionsUnited States
-
Yale UniversityNational Institute of Nursing Research (NINR); The Glimpse Group IncRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Palleon Pharmaceuticals, Inc.CompletedMelanoma | Cancer | Breast Cancer | Head and Neck Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | NSCLC | Non Small Cell Lung Cancer | Bladder Cancer | Colon Cancer | Urothelial Cancer | Oncology | CRC | Esophagogastric Junction Cancer | EGJUnited States
-
MiRXES Pte LtdRecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Thoracic Cancer | Liver CancerSingapore
-
University of California, San DiegoWithdrawnCervical Cancer | Cervical Cancer Stage | Cervical Cancer Stage IB2 | Cervical Cancer Stage IB1 | Cervical Cancer Stage I | Cervical Cancer Stage IB | Cervical Cancer Stage II | Cervical Cancer Stage IIa | Cervical Cancer, Stage IIB | Cervical Cancer, Stage III | Cervical Cancer Stage IIIB | Cervical Cancer... and other conditionsUnited States
Clinical Trials on a mobile app-delivered Acceptance Commitment Therapy (ACT)
-
Duke UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedType 1 Diabetes Mellitus | Eating DisordersUnited States
-
Linkoeping UniversityActive, not recruiting
-
Anne Roche, MACompletedQuality of Life | AgingUnited States
-
VA Office of Research and DevelopmentUniversity of Alabama, TuscaloosaCompletedPsychological StressUnited States
-
Belfast Health and Social Care TrustQueen's University, Belfast; Trauma and Orthopaedics Research CharityNot yet recruitingKnee Osteoarthritis | Total Knee ArthroplastyUnited Kingdom
-
St. Olavs HospitalNorwegian University of Science and TechnologyRecruitingPost-Concussion Syndrome | Post-Traumatic HeadacheNorway
-
Indiana UniversityRegenstrief Institute, Inc.CompletedAnxiety | Anxiety Disorders and Symptoms | Caregiver BurnoutUnited States
-
Central Finland Hospital DistrictUniversity of Jyvaskyla; Finnish Diabetes AssociationCompleted
-
King's College Hospital NHS TrustKing's College London; Barts & The London NHS Trust; University Hospital Southampton... and other collaboratorsCompleted
-
University of California, San FranciscoCompletedCancer RecurrenceUnited States